JACOBUS 25 102 (Dapsone 25 mg)
Pill imprint JACOBUS 25 102 has been identified as Dapsone 25 mg.
Dapsone is used in the treatment of dermatitis herpetiformis; bullous pemphigoid; pneumocystis pneumonia prophylaxis; pemphigoid; linear iga disease (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- JACOBUS 25 102
- Strength:
- 25 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Leprostatics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Jacobus Pharmaceutical Company
- National Drug Code (NDC):
- 49938-0102
- Inactive Ingredients:
- silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
| NDC Code | Manufacturer / Repackager |
|---|---|
| 13925-0504 | Seton Pharmaceuticals LLC |
| 55289-0188 | PDRX Pharmaceuticals Inc (repackager) |
| 54868-2817 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about dapsone
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
